Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance.

Li X, Cai S, Yin W, Hu X, Zhang S, Li Z, Li X, Laudon M.

Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):485-6. doi: 10.1093/abbs/gmw015. No abstract available.

PMID:
27025603
2.

Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.

Mosińska P, Socała K, Nieoczym D, Laudon M, Storr M, Fichna J, Wlaź P.

Behav Brain Res. 2016 Jul 1;307:199-207. doi: 10.1016/j.bbr.2016.03.036.

PMID:
27016427
3.

Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.

Fu W, Xie H, Laudon M, Zhou S, Tian S, You Y.

Psychopharmacology (Berl). 2016 Jun;233(12):2229-39. doi: 10.1007/s00213-016-4272-3.

PMID:
27007604
4.

The U.S. Culture Collection Network Lays the Foundation for Progress in Preservation of Valuable Microbial Resources.

McCluskey K, Alvarez A, Bennett R, Bokati D, Boundy-Mills K, Brown D, Bull CT, Coffey M, Dreaden T, Duke C, Dye G, Ehmke E, Eversole K, Fenstermacher K, Geiser D, Glaeser JA, Greene S, Gribble L, Griffith MP, Hanser K, Humber R, Johnson BW, Kermode A, Krichevsky M, Laudon M, Leach J, Leslie J, May M, Melcher U, Nobles D, Fonseca NR, Robinson S, Ryan M, Scott J, Silflow C, Vidaver A, Webb KM, Wertz JE, Yentsch S, Zehr S.

Phytopathology. 2016 Jun;106(6):532-40. doi: 10.1094/PHYTO-02-16-0074-RVW.

5.

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.

Zielińska M, Jarmuż A, Sałaga M, Kordek R, Laudon M, Storr M, Fichna J.

Naunyn Schmiedebergs Arch Pharmacol. 2016 May;389(5):511-9. doi: 10.1007/s00210-016-1214-x.

6.

Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models.

Buendia I, Gómez-Rangel V, González-Lafuente L, Parada E, León R, Gameiro I, Michalska P, Laudon M, Egea J, López MG.

Neuropharmacology. 2015 Dec;99:187-95. doi: 10.1016/j.neuropharm.2015.07.014.

PMID:
26188145
7.

Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Laudon M, Frydman-Marom A.

Int J Mol Sci. 2014 Sep 9;15(9):15924-50. doi: 10.3390/ijms150915924. Review.

8.

Melatonin receptors in diabetes: a potential new therapeutical target?

She M, Laudon M, Yin W.

Eur J Pharmacol. 2014 Dec 5;744:220-3. doi: 10.1016/j.ejphar.2014.08.012.

PMID:
25160745
9.

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.

Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.

Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625.

10.

Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307.

She M, Hou H, Wang Z, Zhang C, Laudon M, Yin W.

Biochimie. 2014 Aug;103:126-30. doi: 10.1016/j.biochi.2014.05.001.

PMID:
24846082
11.

Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.

Liu YY, Yin D, Chen L, Qu WM, Chen CR, Laudon M, Cheng NN, Urade Y, Huang ZL.

Psychopharmacology (Berl). 2014 Oct;231(20):3973-85. doi: 10.1007/s00213-014-3530-5.

PMID:
24700387
12.

Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.

Chen C, Fichna J, Laudon M, Storr M.

World J Gastroenterol. 2014 Feb 7;20(5):1298-304. doi: 10.3748/wjg.v20.i5.1298.

13.

Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.

She M, Hu X, Su Z, Zhang C, Yang S, Ding L, Laudon M, Yin W.

Eur J Pharmacol. 2014 Mar 15;727:60-5. doi: 10.1016/j.ejphar.2014.01.037.

PMID:
24486392
14.

Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats.

Huang L, Zhang C, Hou Y, Laudon M, She M, Yang S, Ding L, Wang H, Wang Z, He P, Yin W.

Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2449-56.

15.

Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL.

Wang PP, She MH, He PP, Chen WJ, Laudon M, Xu XX, Yin WD.

Biochimie. 2013 Aug;95(8):1650-4. doi: 10.1016/j.biochi.2013.05.005.

PMID:
23707538
16.

Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation.

Thatcher TH, Hsiao HM, Pinner E, Laudon M, Pollock SJ, Sime PJ, Phipps RP.

Am J Physiol Lung Cell Mol Physiol. 2013 Jul 15;305(2):L165-74. doi: 10.1152/ajplung.00036.2013.

17.

A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.

He P, Ouyang X, Zhou S, Yin W, Tang C, Laudon M, Tian S.

Horm Behav. 2013 Jun;64(1):1-7. doi: 10.1016/j.yhbeh.2013.04.009.

PMID:
23651610
18.

Cardiovascular effects of melatonin receptor agonists.

Paulis L, Simko F, Laudon M.

Expert Opin Investig Drugs. 2012 Nov;21(11):1661-78. doi: 10.1517/13543784.2012.714771. Review.

PMID:
22916799
19.

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.

Grossman E, Laudon M, Zisapel N.

Vasc Health Risk Manag. 2011;7:577-84. doi: 10.2147/VHRM.S24603. Review.

20.

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.

Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N.

Diabetes Metab Syndr Obes. 2011;4:307-13. doi: 10.2147/DMSO.S23904.

Items per page

Supplemental Content

Loading ...
Support Center